GLAXO ADMITS ITS EXECUTIVES BROKE CHINESE LAW IN CORRUPTION SCANDAL
July 1st, 2013
MEDICINES giant GSK yesterday (July 22) admitted that its executives had broken Chinese law in a corruption scandal that could see the UK-based company face heavy fines. Following a meeting with Chinese public security ministry officials into their investigation into allegations that GSK executives bribed officials to boost sanctioned prices for its drugs, GSK international president for Europe, Japan, emerging markets and the Asia-Pacific region Abbas Hussain said: “Certain senior executives of GSK China who know our systems well, appear to have acted outside ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.